Preferred Buyer Location All Countries Except India
Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic seizures.Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown to reduce partial (focal) seizures by 50% or more as an add-on medication.It is also used in veterinary medicine for similar purposes.
Member Since 7 Years
Nature of Business Manufacturer
GST No. 24ABNFA9852CIZD
For Buyer 
For Seller 
Help 
Dandi Road, Surat, Gujarat 
Send Enquiry